ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1397	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	cancer treatment 0.423589 PDQ cancer information 0.483377 lymph flow 0.481362 leg 0.408261 left lymph duct 0.48735 white blood cells 0.398624 secondary lymphedema 0.507085 clinical trials 0.422847 cancer information summary 0.440651 clinical trial 0.38593 tiny lymph vessels 0.509598 breast cancer patients 0.459436 sentinel lymph node 0.518746 certified lymphedema therapists 0.498842 breast cancer survivors 0.394173 upper-body exercise 0.39564 NCI PDQ cancer 0.395621 Untreated lymphedema 0.491735 lymph nodes 0.686068 swollen area 0.380684 radiation therapy 0.378654 treatment 0.447311 Lymphedema section 0.47523 lymphedema sleeves 0.47753 severe lymphedema 0.470942	skin 0.4219 Cancer Information Service 0.379239 Primary lymphedema 0.49612 lymph 0.792134 body tissues 0.403337 larger lymph vessels 0.508148 Stage III lymphedema 0.489621 National Cancer Institute 0.439823 arm 0.413813 lymphedema therapist 0.534874 Palliative Care Editorial 0.381473 lymph vessels 0.714976 limb 0.427251 lymphedema 0.932301 certified lymphedema therapist 0.527418 breast cancer 0.483638 Care Editorial Board 0.382648 pressure garment 0.387805 lymphedema increases 0.491902 swollen limb 0.388807 lymph fluid 0.457795 cancer information summaries 0.378678 comprehensive cancer information 0.377712 cancer 0.547119	CLICK HERE
1448	National Cancer Institute	Html	en	Bladder and Other Urothelial Cancers Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for bladder cancer.	bladder cancers 0.459113 individual developing bladder 0.462762 bladder cancer patients 0.501836 Cancer Statistics Review 0.390961 transitional cell carcinoma 0.372436 American Cancer Society 0.389675 bladder cancer 0.911425 Bladder histological changes 0.431525 bladder cancer outcome 0.469139 bladder cancer cases 0.467655 Malignant bladder tumors 0.429947 bladder neoplasms 0.417201 bladder tumours 0.413309 repetitive hematuria screening 0.375531 bladder cancer risk 0.493294 bladder tumors 0.476533 superficial bladder cancer 0.470192 hematuria screening studies 0.380947 bladder toxicity 0.421878 Natl Cancer Inst 0.460204 newly diagnosed bladder 0.471386 Bladder Cancer Group 0.465328 metastatic bladder cancer 0.508614 neuropathic bladder 0.420139 et al. 0.424244	SEER Cancer Statistics 0.388904 bladder carcinogenesis 0.425543 bladder wall 0.415168 bladder cancer mortality 0.489217 bladder tumor antigen 0.4299 bladder cancer. 0.44027 urothelial bladder cancer 0.487451 Cancer Epidemiol Biomarkers 0.435283 urothelial cancer 0.372416 smoking related bladder 0.437945 PUBMED Abstract 0.468199 hematuria home screening 0.413339 bladder cancer case-fatality 0.488876 invasive bladder cancer 0.504621 Superficial bladder tumor 0.43348 National Cancer Institute 0.389198 Bladder cancer incidence 0.470999 bladder malignancies 0.448894 Epidemiol Biomarkers Prev 0.405245 bladder tumor incidence 0.430849 Bladder cancer screening 0.490371 Abstract 0.469966 recurrent bladder tumors 0.444789 urinary bladder cancer 0.487624	CLICK HERE
1544	National Cancer Institute	Html	en	Adult Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.	adult aml 0.716289 red blood cells 0.594071 cancer treatment 0.467513 blood -forming cells 0.4491 acute myeloblastic leukemia 0.44585 acute myelogenous leukemia 0.445245 chemotherapy 0.473847 PDQ cancer information 0.503817 white blood cells 0.675945 clinical trials 0.938073 mature blood cells 0.50039 cancer information summary 0.459101 clinical trial 0.615294 stem cells 0.519631 stem cell transplant 0.480735 acute granulocytic leukemia 0.446114 Myeloid Leukemia Treatment 0.448761 blood cells 0.735668 radiation therapy 0.468603 treatment 0.673705 myeloid stem cell 0.438755 stored stem cells 0.437216 immature blood cells 0.448693 arsenic trioxide 0.473356	cancer cells 0.602593 specific cancer cells 0.456728 recurrent adult aml 0.474546 untreated adult aml 0.465491 acute myeloid leukemia 0.930922 stem cell 0.533281 treatment clinical trials 0.44329 blood stem cells 0.488116 National Cancer Institute 0.460343 spinal cord 0.512703 normal cells 0.467456 myeloid stem cells 0.482174 new treatment 0.480473 white blood cell 0.463646 combination chemotherapy 0.472241 bone marrow 0.747056 cells 0.827248 acute promyelocytic leukemia 0.5928 cancer clinical trials 0.452604 acute nonlymphocytic leukemia 0.445812 acute lymphoblastic leukemia 0.434651 acute leukemia 0.43925 cancer 0.808047 standard treatment 0.467846	CLICK HERE
1548	National Cancer Institute	Html	en	Breast Cancer Screening (PDQ®)–Patient Version	Mammogram, clinical breast exam (CBE), and MRI (magnetic resonance imaging) tests are used to screen for breast cancer. Learn about this and other tests that have been studied to detect or screen for breast cancer in this expert-reviewed summary.	cancer screening methods 0.42533 fast-growing breast cancer 0.440825 ongoing clinical trials 0.389452 following PDQ summaries 0.382952 PDQ cancer information 0.474492 following PDQ summary 0.39258 breast fluid 0.391775 common screening test 0.39988 routine breast cancer 0.436027 clinical trials 0.527662 cancer information summary 0.430839 breast tissue sampling 0.438767 breast cancer prevention 0.479726 test results 0.400913 test 0.410305 Yearly MRI screening 0.382239 NCI PDQ cancer 0.406053 women 0.476763 PDQ Screening 0.392324 stage breast cancer 0.437499 screening tests 0.377685 breast cancer diagnosis 0.443317 clinical breast exams 0.420114 regular breast 0.389266 Cancer Information Service 0.377203	breast cancers 0.414043 denser breast tissue 0.419753 breast duct 0.396464 breast tissue 0.495937 Prevention Editorial Board 0.379673 annual screening mammogram 0.410065 National Cancer Institute 0.431327 Cancer Screening Overview 0.412144 breast cancer benefit 0.435864 breast biopsy result 0.412172 lymph vessels 0.375923 breast tumors 0.395991 breast cancer screening 0.602061 Cancer screening trials 0.429799 clinical breast exam 0.420394 breast cancer 0.970368 clinical breast 0.421091 dense breast tissue 0.418481 PDQ summary 0.443066 false-positive screening mammogram 0.452332 breast self-exams 0.40904 cancer information summaries 0.380757 comprehensive cancer information 0.380439 screening mammogram 0.469345	CLICK HERE
1669	National Cancer Institute	Html	en	Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood craniopharyngioma	evidence 0.541909 subtotal resection 0.652496 intensity-modulated photon therapy 0.593647 Aylwin et al. 0.579904 Merchant TE 0.567828 radiation therapy section 0.596714 PDQ cancer information 0.54907 Conventional radiation therapy 0.591705 Tumors Treatment Overview 0.55265 radiation dose 0.548781 Int J Radiat 0.614894 photon radiation therapy 0.573627 craniopharyngiomas 0.555197 cancer information summary 0.541422 Radiat Oncol Biol 0.7952 irradiated craniopharyngioma 0.570882 standard fractionated radiation 0.630603 Tan et al. 0.575816 conformal radiation treatments 0.560832 proton therapy 0.60593 tumor control 0.588032 common solid tumor 0.565687 recurrent cystic tumor 0.550194 radiation therapy 0.986329 Morisako et al. 0.5808	spare normal tissue 0.555535 Neurosurg Focus 0.546254 et al. 0.839112 complete resection 0.561879 magnetic resonance imaging 0.576707 newer radiation technologies 0.623865 gross-total resection 0.656285 brain tumor treatment 0.599377 residual craniopharyngioma 0.590756 pediatric craniopharyngioma 0.701375 stereotactic radiation therapy 0.599058 PUBMED Abstract 0.577489 craniopharyngioma cyst growth 0.621968 childhood craniopharyngioma 0.72734 Abstract 0.609429 external-beam radiation therapy 0.569508 pediatric brain tumors 0.558017 Sterkenburg et al. 0.578437 Oncol Biol Phys 0.807866 Neurosurg Pediatr 0.63126 recurrent craniopharyngioma 0.572364 papillary craniopharyngioma 0.570471 tumor 0.617686 craniopharyngioma 0.809351	CLICK HERE
1953	National Cancer Institute	Html	es	Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de los problemas de salud que continúan o aparecen después de terminar un tratamiento de cáncer.	válvulas cardíacas 0.300344 digestivasLos efectos tardíos 0.301994 siguientes procedimientos 0.300445 células madre 0.31868 suficiente saliva 0.300202 adultos jóvenes 0.300215 tumor tipo 0.3006 leucemia linfocítica aguda 0.300977 leucemia linfoblástica aguda 0.303718 diabetes mellitus 0.300401 rayos x 0.300187 largo plazo 0.301433 alta densidad 0.300367 debilidad súbitos 0.300398 efectos tardíos 0.995697 luz solar 0.30049 tumores benignos 0.300573	siguientes maneras 0.300324 hormonas tiroideas 0.300415 antecedentes familiares 0.302575 revestimiento protector 0.300332 hepatitis b 0.300262 siguientes factores 0.300516 radiación uv 0.300991 topoisomerasa ii 0.300497 suficiente insulina 0.300239 cuerpo elabora insulina 0.300315 Radiografía panorámica 0.300213 leucemia mieloide aguda 0.302575 mandíbulasLos problemas 0.300385 cáncer infantil meses 0.303991 biliaresLos efectos tardíos 0.30194 Mayor tiempo 0.300312 siguientes pruebas 0.300654	CLICK HERE
2056	National Cancer Institute	Html	es	Píldoras anticonceptivas y el riesgo de cáncer	Hoja informativa acerca de la investigación sobre el riesgo de padecer cáncer de seno, de cérvix, de hígado y de ovarios por el uso de anticonceptivos orales.	oral contraceptives 0.31866 associated with 0.302278 hereditary ovarian cancer 0.307224 anticonceptivos orales 0.994735 combined estrogen-progestogen 0.301637 brca1 or brca2 0.301383 Carrier Cohort Study 0.301448 Disease Control 0.30169 tumores benignos 0.304773 femeninas naturales estrógeno 0.301612 Child Health 0.30166 Steroid Hormone Study 0.30142 IARC Monographs 0.301103 collaborative reanalysis 0.302305 ovarian cancer 0.328123 IARC Working Group 0.301458 Estados Unidos 0.301544 cervical cancer 0.319583 Hormonas Esteroides 0.301394 PubMed Abstract 0.41376 menor riesgo 0.304581 hormonal factors 0.3025 BRCA2 mutation 0.301911 Ovarian Cancer Clinical 0.303961 altas concentraciones 0.302166	efecto protector 0.30213 BRCA2 mutation carriers 0.301397 anticonceptivo oral combinado” 0.302358 alto riesgo 0.304148 Carcinogenic Risks 0.301908 Hunter DJ 0.301541 oral contraception 0.301256 Endocrine-Related Cancer 0.303484 benign liver tumours 0.301157 Epidemiology Biomarkers 0.302164 Cancer Research 0.303353 epidemiological studies 0.304291 National Institute 0.301484 estrogen-progestogen menopausal therapy 0.3011 hormonal contraceptives 0.302747 Human Development 0.301691 IARC commitment 0.301082 breast cancer 0.314784 cuello uterino 0.311204 associated with oral-contraceptive 0.301437 Cancer Institute 0.303378 Colditz GA 0.301768 Combined estrogen-progestogen contraceptives 0.301471 prospective study 0.301048	CLICK HERE
3422	National Cancer Institute	Html	es	Reconstrucción del seno después de una mastectomía	Hoja informativa que describe la reconstrucción del seno (mama) después de una mastectomía. Contiene información sobre las opciones quirúrgicas, los cuidados de seguimiento y los exámenes de detección del cáncer de seno después de la reconstrucción.	cirugía abdominal 0.39888 ley whcra 0.35286 Nipple-sparing mastectomy—is it 0.332063 Cordeiro PG 0.320216 colgajo siep 0.393996 Colgajo TRAM 0.39889 suficiente piel 0.387487 largo plazo 0.34858 large cell lymphoma 0.395571 reconstruction following surgery 0.356853 Reconstructive Surgery 0.417753 Colgajo SGAP 0.397479 Colgajo PAP 0.399861 Colgajo Latissimus 0.401399 PubMed Abstract 0.945047 Colgajo TUG 0.398937 colgajo diep 0.587224 Surgical Oncology Clinics 0.338406 Cirugía oncoplástica.  0.339864 La Cruz L 0.324776 NCI titulada Mamografías 0.32023 breast reconstruction 0.705756 colgajo igap 0.469394 pequeños trozos 0.3196 suficiente tejido 0.3777	colgajos ld 0.342761 Colgajo SIEA 0.398955 Da Lio A 0.329732 implantes de solución 0.348682 reconstruction after surgery 0.366752 therapy implications following 0.337385 suficiente volumen 0.324436 reconstrucción retardada 0.559365 Breast reconstruction after 0.445489 reconstruction after mastectomy 0.350953 Petit JY 0.31974 Breast Disease 0.377661 Cancer Rights Act 0.334748 Reviews Clinical Oncology 0.3359 oncoplastic breast-conserving surgery 0.341614 Total skin sparing 0.332343 técnica llamada 0.357673 sensibilidad conforme crecen y 0.339464 anaplastic large cell 0.394345 New England Journal 0.330568 ¿qué tipo 0.325566 physical therapy 0.407423 systematic reviews 0.354768 Surgical Oncology 0.355698	CLICK HERE
16184	National Cancer Institute	Html	es	Manejo de costos y de información médica	Las personas con cáncer y sus familias pueden enfrentarse a mayores retos económicos. El tratamiento de cáncer puede ser muy caro, aun cuando se tenga seguro. Aprenda cómo mantener la cuenta de tratamientos y de pruebas, de formularios y cobros, y más.	cuáles tratamientos 0.380156 Busque programas 0.344502 información médica clave.  0.356222 médico muestras 0.355273 expediente personal 0.405493 Health Information Management 0.361343 importante cuál sistema 0.365142	mayores retos 0.375386 Busque asistencia 0.353171 Busque formas 0.327721 Sociedad Americana 0.349375 busque ayuda 0.333405 seguro médico 0.91222 mano.  revise cuáles 0.413273	CLICK HERE
16776	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de Cancell/Cantron/Protocel como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Questionable methods 0.583285 NCI Tumor Cell 0.253187 Alternative Cancer Treatment 0.949939 Cancell Alternative Cancer 0.909029 physiological consequences 0.221271 Dills WL Jr 0.236274 Pedersen PL 0.220212 James V 0.220328 CA Cancer 0.715566 Instituto Nacional 0.460523 Tumor Cell Line 0.306478 Livingston-Wheeler therapy 0.223682 nombre cancell 0.23058 Estados Unidos 0.337461 mutational events that 0.237295 Cassileth BR 0.27252 Complementary Therapies 0.275875 tumour glycolysis 0.221381 Oncogenic alterations 0.222154 NCI-60 DTP Human 0.237422 Eastern District 0.221187 WW Norton 0.271304 Bioenerg Biomembr 0.223121 peso promedio 0.220355 District Court 0.221556	Alternative Medicine Handbook 0.357021 Edmund J 0.22088 United States 0.221128 bacteria p 0.221477 Semenza GL 0.221681 diabetes mellitus 0.223111 llamó entelev 0.224971 tipo cancell 0.228779 vía oral 0.22206 Winter Works 0.543066 Trends Biochem Sci 0.237977 critical role 0.221303 Dang CV 0.220582 Mathupala SP 0.220471 National Cancer Institute 0.327107 Aberrant glycolytic metabolism 0.237912 Permanent Injunction 0.223017 New York 0.262714 accessed april 0.557875 Cell Line Screen 0.307726 Physician Data Query 0.23188 Complete Reference Guide 0.33124 células primitivas resultantes 0.275971 Máxima concentración 0.230742	CLICK HERE